FDA Approved: SKYCLARYS — Supplemental Application (Biogen)

View source ↗

Summary

The FDA approved Biogen's supplemental application for Skyclarys (omaveloxolone). This approval updates the labeling for this Friedreich's ataxia therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• SKYCLARYS (omaveloxolone)

Snippet

SUPPL AP for SKYCLARYS (OMAVELOXOLONE)